These results may facilitate the development of early-warning immune predictors and therapeutic strategies for HPV16(+) CIN based on the TIGIT and KLRG1 inhibitory pathways of NK cells. This evidence concerns the gene KLRG1 and cervical squamous intraepithelial neoplasia.